Sigachi Industries
38.40
+0.13(+0.34%)
Market Cap₹1,462.40 Cr
PE Ratio-33.99
IndustryHealthcare
Company Performance:
1D+0.34%
1M-13.47%
6M-8.68%
1Y-24.82%
5Y-35.84%
View Company Insightsright
More news about Sigachi Industries
07Aug 25
Sigachi Industries Expands MCC Capacity, Addresses Share Pledge Invocation
Sigachi Industries has initiated a 12,000 MTPA Microcrystalline Cellulose (MCC) project at its Dahej SEZ unit, set to be operational within 9 months, increasing total MCC capacity to 30,000 MTPA. The new facility will incorporate enhanced safety features following a recent incident at the Pashamylaram unit. Additionally, promoter Amit Raj Sinha's shareholding decreased from 6.15% to 5.90% due to invocation of 10,00,000 pledged shares by KNAB Finance Advisors Pvt Ltd.
07Aug 25
Sigachi Industries Expands MCC Production with 12,000 MTPA Dahej Project, Reaffirming Growth Strategy
Sigachi Industries Limited announces a significant expansion of its microcrystalline cellulose (MCC) manufacturing capacity. The company will add a new 12,000 MTPA project at its Dahej Special Economic Zone unit in Gujarat, expected to be operational within 9 months. This expansion will increase Sigachi's total installed MCC capacity from 18,000 MTPA to 30,000 MTPA, reinforcing its position as India's largest MCC manufacturer. The project features an advanced Spray Dryer system designed with a focus on safety and excellence. This expansion aims to enhance operational resilience, ensure business continuity, and improve customer service across its global clientele in 65+ countries.
06Aug 25
Sigachi Industries Promoter Amit Raj Sinha Faces Pledge Invocation of 10 Lakh Shares
Amit Raj Sinha, a key promoter of Sigachi Industries Limited, reported the invocation of 10 lakh pledged shares on August 1, 2025. This represents 0.26% of the company's total share capital. Following the invocation, Sinha's personal shareholding decreased from 6.15% to 5.24%, with pledged shares reducing from 0.66% to 0.39%. The total promoter group holdings now stand at 36.25% of the company's share capital. The disclosure was made in compliance with SEBI regulations.
01Aug 25
Sigachi Industries Reports INR121 Crore Loss from Hyderabad Plant Fire, Expects Limited Impact on Bottom Line
Sigachi Industries reported a INR121.01 crore loss due to a fire at its Pashamylaram unit. The incident damaged plant, machinery, and stock, affecting 29% of total capacity. Insurance claims of INR90 crores have been filed, with additional coverage for business interruption. The unit is expected to be non-operational for 180 days, impacting revenue by INR60 crores. Q1 FY2026 results show increased operating income but a net loss. The company is proceeding with growth initiatives including R&D center launch and new facility developments. Compensation has been provided to affected employees' families.
29Jul 25
Sigachi Industries: RPS Industries Invokes 510,000 Pledged Shares, Reducing Stake to 19%
RPS Industries Private Limited invoked 510,000 pledged shares of Sigachi Industries Limited on July 24, 2025, reducing its stake from 19.71% to 19.00%. The shares were encumbered in favor of Jio Finance Services Limited. This invocation represented 0.13% of Sigachi's total share capital. The disclosure was made to BSE and NSE on July 28, 2025, in compliance with SEBI regulations.
25Jul 25
Sigachi Industries Reports Q1 Results Amid Tragic Fire Incident
Sigachi Industries Ltd. reported mixed Q1 results, with revenue up 33.99% to ₹1,282.00 crore, but a net loss of ₹1,010.00 crore due to a ₹1,210.00 crore exceptional item related to a fire incident. The June 30 fire at their Hyderabad plant resulted in 46 fatalities and 28 injuries. Operations at the affected unit are halted for 180 days, with an estimated ₹60.00 crore revenue loss. The company is reallocating production, focusing on safety, and continuing strategic initiatives including capacity expansions and API growth.
25Jul 25
Sigachi Industries Reports Q1 Loss Amid Tragic Fire Incident at Hyderabad Plant
Sigachi Industries, a manufacturer of pharmaceutical excipients and APIs, reported a net loss of ₹100.97 crore in Q1, despite a 33.99% increase in revenue to ₹128.25 crore. The loss was primarily due to a fire at its Hyderabad facility on June 30, resulting in 46 fatalities and significant damage. The incident led to a temporary suspension of operations at the 6,400 MTPA Hyderabad unit, causing an estimated revenue loss of ₹60 crore. The company has initiated safety audits, begun phased restoration of the affected unit, and reallocated production to other sites. Management expects a strong recovery in the second half of the year.
23Jul 25
Sigachi Industries Disburses ₹5.80 Crore in Interim Compensation Following Pashamylaram Unit Incident
Sigachi Industries has begun disbursing ₹5.80 crore in interim compensation to families affected by an incident at its Pashamylaram unit in Hyderabad. The company is providing ₹10 lakh each to 15 families of deceased team members, ₹15 lakh each to 8 families of unaccounted team members, and ₹1 lakh each to 25 injured employees. Sigachi is also covering all medical expenses for affected employees, with three individuals still under care. The company has formed an internal task force for relief efforts and is cooperating with an external safety review committee to enhance safety protocols.
18Jul 25
Sigachi Industries: Telangana Plant Explosion Death Toll Climbs to 46
The death toll from the explosion at Sigachi Industries' pharmaceutical plant in Telangana has increased to 46. Eight individuals remain hospitalized, and eight others are still missing. Police have filed an FIR against the company management, and the Telangana government has announced a compensation of ₹1.00 crore for each deceased individual's family. The incident is likely to have serious legal, financial, and operational implications for Sigachi Industries.
02Jul 25
Sigachi Industries Shares Plunge 11% Amid Fatal Fire Aftermath
Sigachi Industries' stock price fell nearly 11% on Wednesday, marking the third consecutive day of decline after a fire at its Hyderabad facility claimed 36 lives on June 30. The company is awaiting clearance from the fire department to resume operations and is cooperating with authorities in rescue and restoration efforts. The incident has raised concerns about safety protocols and potential regulatory scrutiny.
01Jul 25
Sigachi Industries: Telangana CM Announces Rs 1 Crore Compensation for Plant Explosion Victims
An explosion at Sigachi Industries' pharmaceutical plant in Telangana has resulted in 36 fatalities. Chief Minister Revanth Reddy has announced compensation of Rs 1.00 crore for each deceased victim's family. Seriously injured individuals will receive Rs 10.00 lakh, while others injured will get Rs 5.00 lakh. The government has promised immediate relief funds. Expectations are that Sigachi Industries will also contribute to compensation efforts. The incident may have significant implications for the company's operations and industry standing.
30Jun 25
Fire at Sigachi Industries' Hyderabad Plant Halts Operations for 90 Days
Sigachi Industries has suspended operations at its Hyderabad manufacturing facility for an estimated 90 days following a fire incident. The affected plant contributes 6,000 MTPA to the company's total production capacity of 21,700 MTPA. This shutdown may lead to production shortfalls, supply chain disruptions, and potential financial impacts for the quarter.
13Jun 25
Sigachi Industries Secures Approval for New API and Specialty Chemicals Plant
Sigachi Industries has received Terms of Reference (ToR) approval for a new manufacturing plant in Orvakal, Andhra Pradesh, focused on Active Pharmaceutical Ingredients (APIs) and specialty chemicals. This approval is a key step in the company's expansion strategy, potentially enhancing its market position and production capabilities. The project aligns with environmental regulations, suggesting a commitment to sustainable growth. Specific details about investment, capacity, and timelines are yet to be disclosed.
30May 25
Sigachi Industries Reports Mixed Q4 Results: EBITDA Soars, Net Profit Dips
Sigachi Industries' Q4 financial results show significant growth in EBITDA to ₹286.00 million, up from ₹163.00 million year-over-year. EBITDA margin improved to 22.27%, a 6.59 percentage point increase. Revenue grew by 23.08% to ₹1.28 billion. However, consolidated net profit declined 11.33% year-over-year to ₹133.00 million, though it increased quarter-over-quarter.
07May 25
Sigachi Industries Secures European Certification for Metformin Hydrochloride
Sigachi Industries has obtained a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its Metformin Hydrochloride product. This certification validates the quality and safety standards of the product, potentially enhancing the company's access to the European pharmaceutical market. The CEP is expected to provide Sigachi Industries with a competitive advantage and serve as a quality assurance for European regulators and customers.
28Apr 25
Sigachi Industries' Subsidiary Inks MoU with Respilon for Cutting-Edge Nanofiber Drug Delivery Technology
Sigachi Industries' subsidiary, Sigachi MENA FZCO, has signed an MoU with Czech nanotechnology firm Respilon Group to develop and commercialize drug delivery solutions using NUENEX® nanofiber technology. The partnership focuses on creating Invisible Patch and Powder-based pharmaceutical delivery formats, aiming to revolutionize patient experience and improve therapeutic outcomes through non-invasive, precision drug delivery methods.
17Apr 25
Sigachi Industries Secures Environmental Clearance for Dahej 2 SEZ Facility, Paving Way for Expansion
Sigachi Industries Limited has obtained environmental clearance for a new manufacturing facility in Dahej 2 Special Economic Zone, Gujarat. The facility will have a production capacity of 3,120.00 MT/month, focusing on cellulose and starch-based specialized excipients. This strategic move aims to enhance export growth and global competitiveness in pharmaceutical, nutraceutical, and food-grade applications. The environmental clearance, granted on April 16, 2025, allows the company to proceed with site development and execution.
01Apr 25
Sigachi Industries' Stock Climbs 3.33% Amid Promoter Share Pledge and R&D Investment Plans
Sigachi Industries' stock price increased by 3.33% to ₹36.30 on Tuesday, despite overall weak market conditions. This rise occurred despite a recent share pledge by promoter Dharani Devi Chidambaranatham of 9,10,000 shares (0.23% equity). The company announced plans to invest $1 million in a new R&D center in Hyderabad, potentially boosting investor confidence in its growth strategy.
13Mar 25
Sigachi Industries Partners with Indian Navy for Health Initiative in Visakhapatnam
Sigachi Industries Limited has signed an MoU with INS Kalinga of the Indian Navy to launch an eight-month community fitness program in Visakhapatnam. The 'Vizag Navy Marathon Promo cum Conditioning Programme' will run from March to October 2025, featuring monthly events on the second Sunday. This partnership aims to promote health, wellness, and community engagement in the coastal city.
Sigachi Industries
38.40
+0.13
(+0.34%)
1 Year Returns:-24.82%
Industry Peers
Sun Pharmaceutical
1,679.10
(+1.21%)
Divis Laboratories
6,621.50
(+0.32%)
Cipla
1,577.60
(+0.52%)
Torrent Pharmaceuticals
3,584.30
(+1.43%)
Dr Reddys Laboratories
1,255.90
(+1.27%)
Mankind Pharma
2,476.60
(+0.87%)
Zydus Life Science
987.65
(+0.31%)
Lupin
1,940.00
(-0.57%)
Alkem Laboratories
5,581.50
(+1.04%)
Aurobindo Pharma
1,101.00
(-0.48%)